IHS Chemical Week

Lenzing reports lower sales and earnings, speeds up savings plan

11:01 AM MDT | August 21, 2014

Lenzing today reported Ebitda declined 29%, to €91.1 million ($121.9 million), in the first six months of 2014 on 9.1% lower sales of €900.0 million. Ebitda margin declined from 13.7% in the first half of last year to 10.2%. Ebit more than halved, to €32.4 million, compared with €73.8 million in the first six months of 2013. Second-quarter Ebitda was €45.6 million, 52% down on the year-earlier quarter, with sales down from €493.3 million in the second quarter of 2013 to €448.3 million in the latest quarter. The company says it was hurt by difficult...

Access is for Chemweek 24/7 PLUS Members ONLY

This information is only available to Chemweek 24/7 PLUS members who have subscribed to Chemweek’s Business Daily. If you are a member, please log in, OR if you have a trial membership, please use your trial membership account information. 

Username:
Password:

Forgot your user ID or password? Click here to have it sent to you.

 

 

If you are not yet a subscriber and would like to access the turnkey information found only in Chemweek’s Business Daily, subscribe now and you’ll get the most important news of the chemical industry delivered directly to your inbox—every day.

Sign up for a FREE 15-day trial of IHS Chemical Week Business Daily













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa